Trial Profile
A Pilot Study to Explore Preliminary Safety, Tolerability and Efficacy of ORal IrON Supplementation With Ferric Maltol in Treating Iron Deficiency in Patients With Pulmonary Hypertension and Iron Deficiency Anemia
Not yet recruiting
Phase of Trial:
Phase III
Latest Information Update: 18 Jan 2018
At a glance
- Drugs Ferric maltol (Primary)
- Indications Iron deficiency anaemia
- Focus Therapeutic Use
- Acronyms ORION-PH-1
- 01 Nov 2017 New trial record